Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urologic Neoplasms 1Urologic Diseases 1Hypogonadism 1

Interventions

Sunitinib 2tucatinib 1testosterone 17 beta-cypionate 1pembrolizumab 1dodecyl maltoside 1cabozantinib 1Urinary Diversion 1Trastuzumab 1Testosterone Propionate 1Standard of Care 1Saline Solution 1Radiosurgery 1Psychiatric Nursing 1Practice Guidelines as Topic 1Physical Therapy Modalities 1Methyltestosterone 1Lidocaine 1Immune Checkpoint Inhibitors 1Fulvestrant 1Doxycycline 1Cystectomy 1Control Groups 1Ado-Trastuzumab Emtansine 11-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Urologic Neoplasms × Methyltestosterone × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡